- Home
- AMRX vs CPRI Comparison
AMRX vs CPRI Comparison
Compare AMRX & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- CPRI
- Stock Information
- Founded
- AMRX 2002
- CPRI 1981
- Country
- AMRX United States
- CPRI United Kingdom
- Employees
- AMRX N/A
- CPRI N/A
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- CPRI Apparel
- Sector
- AMRX Health Care
- CPRI Consumer Discretionary
- Exchange
- AMRX Nasdaq
- CPRI Nasdaq
- Market Cap
- AMRX 2.5B
- CPRI 2.0B
- IPO Year
- AMRX N/A
- CPRI 2011
- Fundamental
- Price
- AMRX $8.23
- CPRI $18.21
- Analyst Decision
- AMRX Strong Buy
- CPRI Buy
- Analyst Count
- AMRX 4
- CPRI 11
- Target Price
- AMRX $11.50
- CPRI $21.91
- AVG Volume (30 Days)
- AMRX 1.9M
- CPRI 3.3M
- Earning Date
- AMRX 08-08-2025
- CPRI 08-07-2025
- Dividend Yield
- AMRX N/A
- CPRI N/A
- EPS Growth
- AMRX N/A
- CPRI N/A
- EPS
- AMRX N/A
- CPRI N/A
- Revenue
- AMRX $2,830,186,000.00
- CPRI $4,442,000,000.00
- Revenue This Year
- AMRX $9.84
- CPRI N/A
- Revenue Next Year
- AMRX $7.33
- CPRI $4.55
- P/E Ratio
- AMRX N/A
- CPRI N/A
- Revenue Growth
- AMRX 13.42
- CPRI N/A
- 52 Week Low
- AMRX $6.32
- CPRI $11.86
- 52 Week High
- AMRX $9.48
- CPRI $43.34
- Technical
- Relative Strength Index (RSI)
- AMRX 61.71
- CPRI 59.39
- Support Level
- AMRX $8.05
- CPRI $16.22
- Resistance Level
- AMRX $8.24
- CPRI $17.87
- Average True Range (ATR)
- AMRX 0.21
- CPRI 0.71
- MACD
- AMRX 0.03
- CPRI 0.08
- Stochastic Oscillator
- AMRX 90.91
- CPRI 75.40
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About CPRI Capri Holdings Limited
Michael Kors, Versace, and Jimmy Choo are the brands of Capri Holdings, a marketer, distributor, and retailer of upscale accessories and apparel. Michael Kors, Capri's largest brand, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Versace (acquired in 2018) is known for its ready-to-wear luxury fashion, while Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. In April 2025, Capri agreed to sell Versace to Prada. John Idol has served as Capri's CEO since 2003.